Literature DB >> 9817781

Gender- and age-related differences in the regulatory influence of thyroid hormone on the contractility and myosin composition of single rat soleus muscle fibres.

F Yu1, H Degens, X Li, L Larsson.   

Abstract

The effects of 4 weeks of thyroid hormone (3,5,3'-triiodothyronine, T3) treatment on the myosin isoform composition and maximum velocity of unloaded shortening (V0) of single soleus muscle fibres of young (3-6 months) and old (20-24 months) female (149 fibres) and male (200 fibres) rats were studied. Gender-related differences in the up-regulation of fast myosin heavy chain (MyHC) and myosin light chain (MyLC) isoforms were observed. In the female hyperthyroid rats, pure type I fibres and fibres co-expressing type I and type IIA MyHC (type I/IIA fibres) predominated. Some fibres expressed an alpha cardiac-like MyHC isoform either purely (alpha cardiac-like fibre type) or in co-expression with IIA MyHC (alpha cardiac-like/IIA fibre type). In the male hyperthyroid rats, on the other hand, all fibres were either type I/IIA or type I/IIAX. The relative quantities of fast MyLC isoforms in type I/IIA and type I/IIAX fibres was higher in female than in male hyperthyroid rats. V0 was similar in male and female control rats, and decreased with age in both genders (P<0.001). After T3 treatment, the average V0 increased (P<0.001) in females with a concomitant up-regulation of fast MyHC and fast MyLC isoforms irrespective of age. The average V0 of the pooled fibres was higher (P<0.001) in female than in male hyperthyroid rats at both ages. In conclusion, gender- and age-related differences were observed in the regulatory influence of 4 weeks' T3 treatment on myosin isoform composition and V0 in soleus fibres. These differences are presumably related to an interaction of thyroid and sex hormones in the regulation of myosin gene expression.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9817781     DOI: 10.1007/s004240050741

Source DB:  PubMed          Journal:  Pflugers Arch        ISSN: 0031-6768            Impact factor:   3.657


  8 in total

1.  In vitro motility speed of slow myosin extracted from single soleus fibres from young and old rats.

Authors:  P Höök; X Li; J Sleep; S Hughes; L Larsson
Journal:  J Physiol       Date:  1999-10-15       Impact factor: 5.182

Review 2.  Aging-related changes in skeletal muscle. Mechanisms and interventions.

Authors:  L Larsson; B Ramamurthy
Journal:  Drugs Aging       Date:  2000-10       Impact factor: 3.923

Review 3.  Sex-based differences in skeletal muscle kinetics and fiber-type composition.

Authors:  K M Haizlip; B C Harrison; L A Leinwand
Journal:  Physiology (Bethesda)       Date:  2015-01

4.  Identification of a modulator of the actin cytoskeleton, mitochondria, nutrient metabolism and lifespan in yeast.

Authors:  Cierra N Sing; Enrique J Garcia; Thomas G Lipkin; Thomas M Huckaba; Catherine A Tsang; Arielle C Coughlin; Emily J Yang; Istvan R Boldogh; Ryo Higuchi-Sanabria; Liza A Pon
Journal:  Nat Commun       Date:  2022-05-16       Impact factor: 17.694

5.  Effects of elevated thyroid hormone on adult rabbit extraocular muscles.

Authors:  Andrew R Harrison; Michael S Lee; Linda K McLoon
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-07-23       Impact factor: 4.799

6.  Influence of hyperthyroid conditions on gene expression in extraocular muscles of rats.

Authors:  Thomas S Postler; Murat T Budak; Tejvir S Khurana; Neal A Rubinstein
Journal:  Physiol Genomics       Date:  2009-03-10       Impact factor: 3.107

7.  Thyroid hormone regulates muscle fiber type conversion via miR-133a1.

Authors:  Duo Zhang; Xiaoyun Wang; Yuying Li; Lei Zhao; Minghua Lu; Xuan Yao; Hongfeng Xia; Yu-Cheng Wang; Mo-Fang Liu; Jingjing Jiang; Xihua Li; Hao Ying
Journal:  J Cell Biol       Date:  2014-12-15       Impact factor: 10.539

8.  A prolonged hiatus in postmenopausal HRT, does not nullify the therapy's positive impact on ageing related sarcopenia.

Authors:  Gladys L Onambélé-Pearson; David J Tomlinson; Christopher I Morse; Hans Degens
Journal:  PLoS One       Date:  2021-05-05       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.